The ADMIT series - Issues in Inhalation Therapy. 7) Ways to improve pharmacological management of COPD: The importance of inhaler choice and inhalation technique

Primary Care Respiratory Journal

Volumn 20, Issue 3, 2011, Pages 338-343

  Broeders, Mariëlle E A C ^a   Vincken, Walter ^b   Corbetta, Lorenzo ^c  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

COPD; Exacerbation; Inhaler choice; Management; Technique; Therapy

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSULTATION; DISEASE CONTROL; DISEASE EXACERBATION; DRUG CHOICE; DRUG DOSE INCREASE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; INHALATION; INHALATION SPACER; MEDICAL EDUCATION; METERED DOSE INHALER; NEBULIZER; PATIENT COMPLIANCE; PRESCRIPTION; RISK FACTOR; RISK REDUCTION;

DECISION TREES; HUMANS; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY;

EID: 80052602110     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2011.00062     Document Type: Article

References (28)

1. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of COPD. NHLBI/WHO. Update 2006. Available from: URL: http://www.goldcopd.com and www.gold.copd.org
2. Giraud V, Roche N. Misuse of corticosteroid mertered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19:246-5. http://dx.doi.org/10.1183/09031936.02.00218402
3. Hesselink AE, Penninx BW, Wijnhoven HA, Kriegsman DM, van Eijck JT. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scan J Prim Health Care 2001;19:255-60. http://dx.doi.org/10.1080/02813430152706792
4. Barnes PJ. Distribution of receptor targets in the lung. Proc Am Thorac Soc 2004;1:345-51. http://dx.doi.org/10.1513/pats.200409-045MS
5. Crompton GK, Barnes PJ, Broeders M, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team (ADMIT). Respir Med 2006;100:1479-94. http://dx.doi.org/10.1016/j.rmed.2006.01.008
6. Vincken W, Dekhuijzen PN, Barnes P, on behalf of the ADMIT Group. The ADMIT series-Issues in inhalation therapy: 4) How to choose inhaler devices for the treatment of COPD. Prim Care Respir J 2010;19:10-20. http://dx.doi.org/10.4104/pcrj.2009.00062
7. Broeders ME, Sanchis J, Levy ML, Crompton GK, Dekhuijzen PN, on behalf of the ADMIT Working Group. The ADMIT series-Issues in inhalation therapy. 2) Improving technique and clinical effectiveness. Prim Care Respir J 2009;18(2):76-82. http://dx.doi.org/10.4104/pcrj.2009.00025
8. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Executive Summary. Am J Respir Crit Care Med 2007;176:532-55. http://dx.doi.org/10.1164/rccm.200703-456SO
9. Siafakas NM, Vermeire P, Pride NB, et al. on behalf of the Task Force. Optimal assessment and management of COPD. A consensus statement of the European Respiratory Society. Eur Respir J 1995;8:1398-420. http://dx.doi.org/10.1183/09031936.95.08081398
10. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, breath-actuated dry powder inhalers. Chest 1995;105:111-16. http://dx.doi.org/10.1378/chest.105.1.111
11. Sestini P, Cappiello V, Aliani M, et al. Associazione Italiana Pneumologi Ospedalieri Educational Group. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med 2006;19(2):127-36. http://dx.doi.org/10.1089/jam.2006.19.127
12. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of 7 inhalation devices. EDICI. Respir Med 2000;94(5):496-500. http://dx.doi.org/10.1053/rmed.1999.0767
13. Osman LM. Patient preferences and inhaler use in chronic obstructive pulmonary disease. Int J of Resp Care 2006;2(3):95-9.
14. Newman SP, Clarke SW. Therapeutic aerosols 1-Physical and practical considerations. Thorax 1983;38:881-6. http://dx.doi.org/10.1136/thx.38.12.881
15. Goodman DE, Israel E, Rosenberg M, Johnson R, Weiss ST, Drazen JM. The influence of age, diagnosis and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med 1994;150:1256-61.
16. Bellia V, Battaglia S, Matera MG, Cazzola M. The use of bronchodilators in the treatment of airway obstruction in elderly patients. Pulm Pharmacol Ther 2006;19:311-19. http://dx.doi.org/10.1016/j.pupt.2005.08.004
17. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J 2002;78:37-9. http://dx.doi.org/10.1136/pmj.78.915.37
18. Pauwels R, Newman S, Borgström L. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers. Eur Respir J 1997;10:2127-38. http://dx.doi.org/10.1183/09031936.97.10092127
19. Newman SP. Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs? Br J Clin Pharmacol 2000;49:529-37. http://dx.doi.org/10.1046/j.1365-2125.2000.00106.x
20. Lavorini F, Levy ML, Corrigan C, Crompton G, on behalf of the ADMIT Working Group. The ADMIT series-issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir J 2010;19(4):335-41. http://dx.doi.org/10.4104/pcrj.2010.00065
21. Lavorini F, Magnan A, Dubus JC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008;102:593-604. http://dx.doi.org/10.1016/j.rmed.2007.11.003
22. van der Palen J, Klein JJ, Kerkhoff AH, van Herwaarden CL, Seydel ER. Evaluation of the long-term effectiveness of three instruction modes for inhaling medicines. Patient Educ Couns 1997;32(1 Suppl):S87-95. http://dx.doi.org/10.1016/S0738-3991(97)00100-6
23. Crompton GK. Problems patients have using pressurised aerosol inhalers. Eur J Respir Dis 1982;63(Suppl 119):101-04.
24. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of COPD. Ann Intern Med 1987;106:196-204.
25. Tashkin DP, Celli B, Senn S, et al. for the UPLIFT Study Investigators. A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease. N Engl J Med 2008;359:1543-54. http://dx.doi.org/10.1056/NEJMoa0805800
26. Calverley PMA, Anderson JA, Celli B, et al. for the TORCH investigators. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 2007;356:775-89. http://dx.doi.org/10.1056/NEJMoa063070
27. Berry RB, Shinto RA, Wong FH, Despars JA, Light RW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest 1989;96:1241-46. http://dx.doi.org/10.1378/chest.96.6.1241
28. Turner MO, Patel A, Ginsburg S, Fitzgerald JM. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med 1997;157:1736-44. http://dx.doi.org/10.1001/archinte.157.15.1736